Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

2 results about "Lymphoid tissue hyperplasia" patented technology

Bioinformatically-identified control elements for regulated expression of a lentiviral vector to treat x-linked lymphoproliferative disease

PCT designated stage expiredWO2024238764A3Genetic material ingredientsPeptidesLymphoproliferative diseaseLymphoid tissue hyperplasia
Isolated polynucleotides capable of expressing SLAM-associated protein (SAP) mimicking the lineage and stage expression patterns of endogenous SAP, and viral vectors comprising thereof. Further disclosed are methods for treating X-linked lymphoproliferative disease (XLP1).
Owner:RGT UNIV OF CALIFORNIA

Means and methods of combating myeloproliferative disorders or lymphoproliferative disorders

ActiveCN113072644BSerum immunoglobulinsBiological material analysisLymphoid tissue hyperplasiaMyeloproliferative Disorders
The present invention relates to means and methods for combating myeloproliferative disorders or lymphoproliferative disorders. The present invention provides human AML-specific binding compounds capable of binding to a cell surface component of AML cells. Therapeutic applications of the binding compounds against AML are also contemplated.
Owner:KLING BIOTHERAPEUTICS BV